Why is Van den Berg Reaction done ? I mean I know that it's for hyperb

Why is Van den Berg Reaction done ? I mean I know that it's for hyperbilirubinemia and all. But is it still done in labs? Why will we prefer it?

Reading File

Searching the Web

Van den Bergh reaction bilirubin still used modern labs 2024

Finding Sources

Reading Web Page

Van den Bergh reaction principle still used modern labs advantages

Reading File

I now have excellent information from the Tietz Textbook of Laboratory Medicine and Lippincott Biochemistry. Let me give you a thorough, honest answer.

The Van den Bergh Reaction - What It Is, Why It Matters, and Where It Stands Today

The Original Principle (1916)

Van den Bergh and Muller applied Ehrlich's diazo reagent (diazotized sulfanilic acid) to serum bilirubin measurement. The reaction produces reddish-purple azodipyroles (azopigments), measured colorimetrically. The key observation they made was the basis of the whole "direct vs indirect" classification:

Direct bilirubin - reacts with diazo reagent immediately, in aqueous solution, without any accelerator. This is conjugated bilirubin (water-soluble, glucuronate-bound).
Indirect bilirubin - reacts slowly or not at all in aqueous conditions. Needs an accelerator like ethanol/methanol. This is unconjugated bilirubin (hydrophobic, albumin-bound).
Total bilirubin - measured after adding an accelerator (alcohol or caffeine).
Indirect = Total minus Direct (calculated, not directly measured).

The chemistry makes sense: conjugated bilirubin is water-soluble because the glucuronate groups break the internal hydrogen bonds of bilirubin, exposing the azo-coupling sites. Unconjugated bilirubin has tightly intramolecular hydrogen bonds that shield these sites, requiring alcohol to disrupt them.

Why Is It Still "Done" in Labs?

Here's the honest answer: the Van den Bergh reaction as originally described is NOT literally performed in modern labs. What IS still universally done is the diazo reaction principle - specifically the Jendrassik-Grof method (1938), which is a direct evolution of Van den Bergh's work.

What evolved and why:

Feature	Original Van den Bergh	Jendrassik-Grof (modern standard)
Accelerator	Ethanol / methanol	Caffeine + sodium benzoate
Problem solved	-	Avoids protein precipitation by methanol, reduced Hb interference
Reliability	Variable	Reproducible, transferable across labs
Status	Abandoned (Malloy-Evelyn methanol variant now historical only)	Currently the method of choice

The Jendrassik-Grof method works because caffeine displaces unconjugated bilirubin from albumin by forming hydrogen bonds with it, making it water-soluble and reactive with the diazo reagent. This is the diazo bilirubin test running on virtually every modern clinical chemistry analyzer.

So when your textbook says "bilirubin is measured by the Van den Bergh reaction," it means the diazo reaction family that Van den Bergh pioneered - not his exact 1916 procedure.

Why Do We Still Prefer the Diazo/Jendrassik-Grof Method?

Cheap and automatable - runs on every standard clinical chemistry analyzer (Roche, Abbott, Beckman, Siemens). No special equipment needed.
Validated extensively - decades of reference ranges, clinical correlation, and EQAS data are built around this method.
Distinguishes direct vs indirect - clinically this distinction drives the differential diagnosis of jaundice (pre-hepatic vs hepatic vs post-hepatic).
Works for all sample types - serum, plasma, urine, amniotic fluid, cerebrospinal fluid.

What Are the Limitations? (Why Alternatives Exist)

The "direct" fraction does not perfectly equal conjugated bilirubin - it overestimates because unconjugated bilirubin will partially react even in aqueous conditions if given time.
The method cannot measure delta bilirubin (bilirubin covalently bound to albumin, seen in prolonged conjugated hyperbilirubinemia) - this requires HPLC.
For neonatal jaundice, direct spectrophotometry (measuring absorbance at two wavelengths) is preferred because neonates essentially have only unconjugated bilirubin, and transcutaneous bilirubinometers are increasingly used bedside.
HPLC is the gold standard for fractionating all four bilirubin species (alpha, beta, gamma, delta) but is expensive, slow, and not available in routine labs.

The Bottom Line

The Van den Bergh reaction is "done" in every lab in the world - just in its refined Jendrassik-Grof form, automated on analyzers. The name "Van den Bergh" persists in biochemistry teaching because it introduced the conceptual framework of direct/indirect bilirubin and demonstrated that diazo chemistry could quantitate bilirubin fractions - a framework that is still clinically used daily.

We prefer it because it is inexpensive, automatable, reproducible, and clinically sufficient for diagnosing and managing jaundice. The more accurate HPLC methods are reserved for research or highly complex/unusual cases.

Sources: Tietz Textbook of Laboratory Medicine, 7th Ed, Chapter 51 (Liver Disease) | Lippincott Illustrated Reviews: Biochemistry, 8th Ed, Chapter 21

I have a presentation on 'Van den Bergh Test for Bilirubin' for Biochemistry. I need to ace it at any cost. Suggest me a brilliant case as an introduction and another wonderful conclusion to.

Finding Sources

Reading File

Finding Sources

I have everything I need. Here is a presentation-grade intro case and conclusion, both grounded in solid biochemistry and clinical reality.

Opening Case: The Baby Who Slept Too Much

Here's the scenario. Read it out loud slowly as your first slide. It will silence the room.

A 4-day-old boy is brought to the pediatric ward. His mother says he has been unusually sleepy and is feeding poorly. On examination, the resident notices his skin is a bright yellow - from scalp to soles. His sclerae are deeply icteric. His total bilirubin comes back at 38 mg/dL, almost entirely indirect.

The baby does not have liver disease. His urine is clear, not dark. His stools are normal colored. Yet without intervention in the next few hours, this child will sustain permanent brain damage.

What is happening - and what single biochemical distinction, measurable with a test invented in 1916, tells us exactly what is wrong and how urgently to act?

Why this case works:

It immediately answers "why does this test matter?" before you even name it
The numbers are real - Crigler-Najjar Type 1 (complete UGT1A1 loss of function) presents with unconjugated bilirubin of 18-45 mg/dL from birth, lifelong, unresponsive to phenobarbital
The drama is genuine: before phototherapy existed, most Crigler-Najjar Type 1 babies died of kernicterus in infancy
The indirect bilirubin result is the pivot point - it tells you conjugation is broken (not excretion), so the liver's bile system is fine, but the neurotoxic unconjugated bilirubin is flooding across the blood-brain barrier into the basal ganglia

What you say after revealing the answer:

"The Van den Bergh test told us, in minutes, that this baby's problem was upstream - at the conjugation step. That one result changed everything: the diagnosis, the urgency, and the treatment plan. Today we will understand exactly how."

Now you walk into your main content with purpose. The audience is invested.

Closing: The Conclusion That Lands

A great conclusion does three things: zooms out, creates resonance, and ends on one unforgettable line. Here is the structure:

Slide: "What a color change tells us"

We started with a yellow baby and a number. The Van den Bergh test did something elegant - it used chemistry to ask the liver a question: "Did you conjugate this bilirubin or not?" The answer came as a color, in a test tube, in minutes.

Direct bilirubin means conjugation worked - the problem is downstream, in excretion or obstruction. Indirect bilirubin means conjugation failed - the problem is in hepatocytes, in enzyme activity, or in the sheer volume of heme being broken down. That one distinction narrows the entire differential diagnosis of jaundice.

The reaction has been refined - Jendrassik and Grof replaced alcohol with caffeine, modern analyzers run it in seconds - but the core principle is unchanged since 1916. In biochemistry, that longevity is not nostalgia. It is validation.

Final line (say this, don't just put it on a slide):

"Every jaundiced patient you will ever see - newborn or 80 years old - will have a bilirubin reported as direct and indirect. That report exists because of the chemistry we discussed today. A yellow pigment, a diazo reaction, and a color change that still guides clinical decisions a century later."

Why this conclusion works:

It calls back to the opening case ("we started with a yellow baby") - giving the presentation a satisfying arc
It gives your audience one concrete take-home: direct = conjugation worked, indirect = conjugation failed
It acknowledges the test's evolution without dismissing it - showing scientific maturity
The final line is quotable and connects abstract biochemistry to their future clinical lives, which is what examiners and professors genuinely appreciate

One bonus tip: If someone asks you a question you don't know, say - "That's interesting - the test itself can't answer that, which is exactly why HPLC was developed for delta-bilirubin. But in routine practice, the diazo method is sufficient." It shows you know the limits of the test, which is the mark of someone who truly understands it.

Good luck - you're going to be excellent.

Find recent clinical images of jaundiced neonates for your slides and give me the source for the image and this case too. I need to cite it.

Searching the Web

neonatal jaundice clinical image creative commons license free use

Searching the Web

jaundiced newborn baby icteric sclera clinical photo wikimedia commons

Loading Image

Reading Web Page

license author date description

analyse_media

Searching PubMed

Crigler-Najjar syndrome type 1 neonatal bilirubin treatment

Good - I have all the license and citation details. Let me give you everything clearly.

Important Transparency Note First

The clinical case I wrote for you in the previous response was a constructed teaching scenario - it is not a real published case report. It was built from real clinical data (Crigler-Najjar Type 1 bilirubin levels, kernicterus risk, treatment protocols) drawn from Goldman-Cecil Medicine and Tietz Textbook of Laboratory Medicine. You should not cite it as a case report - cite it as a textbook-derived illustrative scenario, or swap it for one of the real published case reports below.

Images You Can Actually Use (Free & Citable)

Image 1 - Jaundiced Newborn (Hypothyroidism-induced)

What it shows: A 6-week-old female infant with visible yellow skin discoloration due to jaundice (caused by hypothyroidism in this case - but the clinical appearance of indirect hyperbilirubinemia is identical regardless of cause).

Citation:

Dr. Hudson. Jaundice in newborn [Photograph]. US Department of Health and Human Services, Image ID #5604. Wikimedia Commons. Public Domain. https://commons.wikimedia.org/wiki/File:Jaundice_in_newborn.jpg

Slide caption to use: "Icteric discoloration of skin in a neonate. Clinically, jaundice becomes visible when serum bilirubin exceeds ~5 mg/dL."

Image 2 - Neonate Under Phototherapy

What it shows: A newborn under blue fluorescent phototherapy lights - the standard first-line treatment for unconjugated hyperbilirubinemia. Perfect for your conclusion slide when you mention that phototherapy converts bilirubin to water-soluble photoisomers.

Citation:

Pot, M. (Martybugs). Newborn infant undergoing phototherapy to treat neonatal jaundice [Photograph]. 2007. Wikimedia Commons. CC BY 3.0. https://commons.wikimedia.org/wiki/File:Jaundice_phototherapy.jpg

Slide caption to use: "Phototherapy converts unconjugated bilirubin to water-soluble photoisomers excretable without conjugation - treatment guided by indirect bilirubin levels from the Van den Bergh test."

Real Published Cases You Can Cite Instead of (or Alongside) the Constructed Case

These are peer-reviewed case reports on neonatal unconjugated hyperbilirubinemia - directly relevant to your scenario:

1. Best fit for your opening scenario:

Kovačić Perica M, Todorić I, Marčinković N. Case report: Crigler-Najjar syndrome type 1 in Croatia - more than a one in a million: a case series. Front Pediatr. 2023. PMID: 37928349

This is a published case series of real Crigler-Najjar Type 1 neonates - exactly the clinical scenario described. You can say: "Cases like these have been described as recently as 2023..."

2. For the differential diagnosis angle (Gilbert vs Crigler-Najjar):

Cozzi L, Nuti F, Degrassi I. Gilbert or Crigler-Najjar syndrome? Neonatal severe unconjugated hyperbilirubinemia with P364L UGT1A1 homozygosity. Ital J Pediatr. 2022 Apr 18. PMID: 35436954

This one actually shows how the direct/indirect bilirubin distinction guides the diagnosis between two UGT1A1 mutation disorders - a perfect tie-in to your Van den Bergh test content.

How to Cite the Textbooks (for the case data)

The bilirubin levels (18-45 mg/dL in CN-1), kernicterus risk, and treatment details in the constructed case came from:

Goldman L, Cooney KA, eds. Goldman-Cecil Medicine, 27th Edition. Elsevier; 2024. Chapter 133: Crigler-Najjar and Gilbert Syndromes.

Tietz NW, Rifai N, eds. Tietz Textbook of Laboratory Medicine, 7th Edition. Elsevier; 2023. Chapter 51: Liver Disease and Bilirubin Measurement.

Quick summary of what to put in your slide footnotes:

Slide	Cite as
Opening case	Goldman-Cecil Medicine, 27th Ed, Ch.133 + PMID 37928349
Image 1 (yellow neonate)	Dr. Hudson / DHHS / Public Domain, Wikimedia Commons
Image 2 (phototherapy)	Martybugs / CC BY 3.0, Wikimedia Commons
Biochemistry of the test	Tietz Lab Medicine, 7th Ed, Ch.51
Conclusion (photoisomers)	Lippincott Biochemistry, 8th Ed, Ch.21

Create a PowerPoint presentation on Van den Bergh reaction with all these citations

Reading File

Running Command

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

This is a shared conversation. Sign in to Orris to start your own chat.